According to an investigation published on bmj.com, hip fractures are 35% more likely to occur in post-menopausal women if they take indigestion medications, known as proton pump inhibitors (PPIs). This figure rises to 50% if the women are former or cu…
Tarsa Therapeutics has presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA™, the company’s oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis…
Bisphosphonates, medications for the treatment and prevention of osteoporosis and other bone conditions, should have additional data on their labels on treatment duration, an FDA Advisory Committee for Reproductive Health Drugs and the Drug Safety and …
If you are already taking moderate amounts of calcium, increasing it will not lower your risk of osteoporosis or fractures when you are older, researchers from Uppsala University in Sweden reported in the BMJ (British Medical Journal). As we get older …
Although bisphosphonates are linked to a tiny risk of a rare type of thigh fracture, their benefits are still far greater than their dangers for the prevention and treatment of osteoporosis, Swedish researchers wrote in the NEJM (New England Journal of…
Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parath…
Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parath…
UCB (Euronext Brussels: UCB) and Amgen (Nasdaq: AMGN) announced today positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody CDP7851/AMG785 to placebo in postmenopausal women with low bone mineral density (BMD) for t…
UCB (Euronext Brussels: UCB) and Amgen (Nasdaq: AMGN) announced today positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody CDP7851/AMG785 to placebo in postmenopausal women with low bone mineral density (BMD) for t…
Women with osteoporosis in their hip suffer menopause two years earlier than healthy women, a study conducted at the University of Granada says. Additionally, although further study is required, researchers have found at least three genetic markers as…
Women with osteoporosis in their hip suffer menopause two years earlier than healthy women, a study conducted at the University of Granada says. Additionally, although further study is required, researchers have found at least three genetic markers as…
Although less likely to suffer a hip or wrist fracture, obese women suffer from fragility fractures at other sites, partly due to poor mobility and increased risk of falls Obesity is widely believed to be protective against fracture, although a recent …
Although less likely to suffer a hip or wrist fracture, obese women suffer from fragility fractures at other sites, partly due to poor mobility and increased risk of falls Obesity is widely believed to be protective against fracture, although a recent …
Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, valid…
Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, valid…
